215 related articles for article (PubMed ID: 23687948)
1. Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester.
Damm P; Mersebach H; Råstam J; Kaaja R; Hod M; McCance DR; Mathiesen ER
J Matern Fetal Neonatal Med; 2014 Jan; 27(2):149-54. PubMed ID: 23687948
[TBL] [Abstract][Full Text] [Related]
2. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
Moy FM; Ray A; Buckley BS; West HM
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009613. PubMed ID: 28602020
[TBL] [Abstract][Full Text] [Related]
3. [The frequency of mild and severe fetal malformations in diabetic women with high values of glycosilated hemoglobin in early pregnancy].
Todorova K; Mazneĭkova V; Ivanov S; Genova M
Akush Ginekol (Sofiia); 2005; 44(3):3-10. PubMed ID: 16028383
[TBL] [Abstract][Full Text] [Related]
4. Need for less tight glucose control in early pregnancy after embryogenesis due to high risk of maternal hypoglycaemia in women with pre-existing diabetes can be compensated by good control in late pregnancy.
Hauffe F; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M; Schaefer-Graf UM
Diabet Med; 2020 Sep; 37(9):1490-1498. PubMed ID: 32583455
[TBL] [Abstract][Full Text] [Related]
5. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
6. Association Between HbA1c Levels on Adverse Pregnancy Outcomes During Pregnancy in Patients With Type 1 Diabetes.
Lemaitre M; Ternynck C; Bourry J; Baudoux F; Subtil D; Vambergue A
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1117-e1125. PubMed ID: 34694409
[TBL] [Abstract][Full Text] [Related]
7. Management of diabetes in pregnancy.
Balaji V; Seshiah V
J Assoc Physicians India; 2011 Apr; 59 Suppl():33-6. PubMed ID: 21823253
[TBL] [Abstract][Full Text] [Related]
8. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes.
Maresh MJ; Holmes VA; Patterson CC; Young IS; Pearson DW; Walker JD; McCance DR;
Diabetes Care; 2015 Jan; 38(1):34-42. PubMed ID: 25368104
[TBL] [Abstract][Full Text] [Related]
9. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy.
Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC
Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes.
Hod M; Mathiesen ER; Jovanovič L; McCance DR; Ivanisevic M; Durán-Garcia S; Brøndsted L; Nazeri A; Damm P
J Matern Fetal Neonatal Med; 2014 Jan; 27(1):7-13. PubMed ID: 23617228
[TBL] [Abstract][Full Text] [Related]
11. Impact of late pregnancy haemoglobin A
Yong SL; Ng BK; Mohd Yassin MAJ; Syed Zakaria SZ; Mohamed Ismail NA
J Obstet Gynaecol; 2018 May; 38(4):461-465. PubMed ID: 29390907
[TBL] [Abstract][Full Text] [Related]
12. Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
Chatterjee S; Jarvis-Kay J; Rengarajan T; Lawrence IG; McNally PG; Davies MJ
Diabetes Res Clin Pract; 2007 Aug; 77(2):215-22. PubMed ID: 17141354
[TBL] [Abstract][Full Text] [Related]
13. Different insulin types and regimens for pregnant women with pre-existing diabetes.
O'Neill SM; Kenny LC; Khashan AS; West HM; Smyth RM; Kearney PM
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011880. PubMed ID: 28156005
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.
Gong Y; Wei T; Liu Y; Wang J; Yan J; Yang D; Luo S; Weng J; Zheng X
J Diabetes; 2024 May; 16(5):e13558. PubMed ID: 38664886
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
Farrar D; Tuffnell DJ; West J; West HM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of pregnancy in women with type 1 diabetes(1).
Taylor R; Lee C; Kyne-Grzebalski D; Marshall SM; Davison JM
Obstet Gynecol; 2002 Apr; 99(4):537-41. PubMed ID: 12039106
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan.
Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA
J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037
[TBL] [Abstract][Full Text] [Related]
18. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes.
Scott EM; Feig DS; Murphy HR; Law GR;
Diabetes Care; 2020 Jun; 43(6):1178-1184. PubMed ID: 32209645
[TBL] [Abstract][Full Text] [Related]
19. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.
Garg SK; Frias JP; Anil S; Gottlieb PA; MacKenzie T; Jackson WE
Endocr Pract; 2003; 9(3):187-93. PubMed ID: 12917059
[TBL] [Abstract][Full Text] [Related]
20. Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes.
Mathiesen ER; Damm P; Jovanovic L; McCance DR; Thyregod C; Jensen AB; Hod M
Diabetes Metab Res Rev; 2011 Sep; 27(6):543-51. PubMed ID: 21557440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
